Page results
-
Patient information for Red Cell Network patients
-
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
Education and training videos for Red Cell Network patients
-
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
-
Well done to everyone who ran to support UCLH in the iconic London Landmarks Half Marathon on 2 April!
-
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
-
The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.
File results
-
FOI/2022/0602 - Number of patients admitted for lung diseases over a five year period
-
FOI/2022/0606 - Breathing circuits supplier
-
FOI/2022/0608 - Patient experience feedback
-
FOI/2022/0609 - Parking for patents/ carers for children/ young people with cancer
-
FOI/2022/0611 - FTE staff, student staff, patients and attendances, bed numbers and occupancy
-
FOI/2022/0612 - Blood transfusions from patients vaccinated with mRNA gene therapy Coronavirus
-
FOI/2022/0615 - Vasectomy operations
-
FOI/2022/0616 - Corporate property and asset information facilities management
-
FOI/2022/0623 - Integration/ workflow solutions across multiple technology systems
-
FOI/2022/0625 - Lung cancer treatment